BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29556617)

  • 1. CDX2 expression can predict response to neoadjuvant therapy in gastric carcinoma.
    Fernández Aceñero MJ; Sánchez de Molina ML; Caso A; Vorwald P; Olmo DG; Palomar J; Estrada L; Díaz Del Arco C
    Rom J Morphol Embryol; 2017; 58(4):1275-1278. PubMed ID: 29556617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma.
    Sánchez de Molina ML; Díaz Del Arco C; Vorwald P; García-Olmo D; Estrada L; Fernández-Aceñero MJ
    Clin Transl Oncol; 2018 Feb; 20(2):253-257. PubMed ID: 28653276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
    Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic influence of CDX2 expression in gastric carcinoma after surgery with a curative intent.
    Estrada Muñoz L; García Gómez de Las Heras S; Díaz Del Arco C; Cerón Nieto MA; Chicharro Uriguen J; Fernández Aceñero MJ
    Rev Esp Enferm Dig; 2019 Jul; 111(7):514-518. PubMed ID: 31140285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
    Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer.
    Gao X; Han W; Chen L; Li H; Zhou F; Bai B; Yan J; Guo Y; Liu K; Li W; Li R; Yuan Q; Zhang J; Lu Y; Zhao X; Ji G; Li M; Zhao Q; Wu K; Li Z; Nie Y
    Cancer Med; 2023 Sep; 12(17):17613-17631. PubMed ID: 37602699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.
    Schildberg CW; Abba M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupold JH; Hohenberger W; Allgayer H
    Adv Med Sci; 2014 Mar; 59(1):142-6. PubMed ID: 24797991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations of the Cdx2 gene in gastric cancer.
    Song JH; Kim CJ; Cho YG; Chae JS; Cao Z; Nam SW; Lee JY; Park WS
    APMIS; 2008 Jan; 116(1):74-80. PubMed ID: 18254783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.
    Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB
    J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo.
    Wei W; Li L; Wang X; Yan L; Cao W; Zhan Z; Zhang X; Yu H; Xie Y; Xiao Q
    Mol Med Rep; 2015 Jul; 12(1):905-12. PubMed ID: 25738600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
    Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
    J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.
    Neumann J; Heinemann V; Engel J; Kirchner T; Stintzing S
    Virchows Arch; 2018 Aug; 473(2):199-207. PubMed ID: 29675807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of guanylyl cyclase-c and caudal type homeobox transcription factor 2 in human gastric cancer and precursor lesions].
    Zhu HJ; Xu Z; Mao ZB; Zhang JF; Zhang JG; Pan ZP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3418-21. PubMed ID: 19159573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells.
    Almeida R; Almeida J; Shoshkes M; Mendes N; Mesquita P; Silva E; Van Seuningen I; Reis CA; Santos-Silva F; David L
    J Pathol; 2005 Dec; 207(4):396-401. PubMed ID: 16278805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.